| Detection of PNH Clones can Aid in the Distinction of Aplastic Anemia vs Inherited BM Failure Syndromes: A Single Center Experience and Review of the Literature |
|
Clinical Lymphoma, Myeloma & Leukemia |
Aplastic Anemia, Paroxysmal Nocturnal Hemoglobinuria (PNH) |
| Determinants of low health-related quality of life in patients with myelodysplastic syndromes: EUMDS Registry study |
|
Blood Advances |
Myelodysplastic Syndromes (MDS) |
| Development of a target concentration intervention to individualize paroxysmal nocturnal hemoglobinuria treatment with pegcetacoplan |
|
Annals of Hematology |
Paroxysmal Nocturnal Hemoglobinuria (PNH) |
| Diagnosis and classification of myelodysplastic syndromes |
|
Blood |
Myelodysplastic Syndromes (MDS) |
| Diagnosis and Classification of Myelodysplastic Syndromes with Mutated TP53 |
|
Clinics in Laboratory Medicine |
Myelodysplastic Syndromes (MDS) |
| Diagnosis and treatment of pediatric myelodysplastic syndromes: A survey of the North American Pediatric Aplastic Anemia Consortium |
|
Pediatric Blood & Cancer |
Aplastic Anemia, Myelodysplastic Syndromes (MDS), Pediatric |
| Diagnosis of myelodysplastic syndromes: the classic and the novel |
|
Haematologica |
Myelodysplastic Syndromes (MDS) |
| Diagnosis of myelodysplastic syndromes: the classic and the novel |
|
Haematologica |
Myelodysplastic Syndromes (MDS) |
| Discordant pathologic diagnoses of myelodysplastic neoplasms and their implications for registries and therapies |
|
Blood Advances |
Acute Myeloid Leukemia (AML), Myelodysplastic Syndromes (MDS), Myeloproliferative Neoplasms (MPN) |
| Disease Burden at the Time of Transplantation Is a Primary Predictor of Outcomes in Pediatric MDS: A Single-Center Experience |
|
Cancers |
Myelodysplastic Syndromes (MDS), Pediatric |
